Genomics of Long‐Term Complications of Childhood Leukemia: Rationale and Design of the GenLEA Study
Mathilde Veneziano‐Broccia(Inserm), Paul Saultier(Inserm), Carine Domenech(Université Claude Bernard Lyon 1), J H Dalle(Assistance Publique – Hôpitaux de Paris), Jean‐François Deleuze(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Gaëlle Munsch(Université de Bordeaux), Julie Berbis(Aix-Marseille Université), Gerard Michel(Aix-Marseille Université), Pascal Auquier(Aix-Marseille Université), Marine Germain(Bordeaux Population Health), Marie‐Dominique Tabone(Sorbonne Université), Robert Olaso(University of Bonn), David‐Alexandre Tregouet(Bordeaux Population Health), Caroline Meguerditchian(Université de Bordeaux)
Cited by 1
Related Papers
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
|Nature Genetics|2017|1.1k
Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia
|Cell stem cell|2023|75
Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism
|Nature Communications|2023|37
Bayesian network analysis of plasma microRNA sequencing data in patients with venous thrombosis
|European Heart Journal Supplements|2020|14
High risk of long-term recurrence after a first episode of venous thromboembolism during pregnancy or postpartum: the REcurrence after a PrEgnAncy related Thrombosis (REPEAT) Study
|Journal of Thrombosis and Haemostasis|2024|12